Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 20/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16619681 | 1.00 | ADRB3 (0.45) | ADRB3SLC6A2KCNH2ADRB2ADRB1 | |
| SCHEMBL16619686 | 0.92 | ADRB3 (0.53) | ADRB3SLC6A2KCNH2ADRB2SLC6A4 | |
| SCHEMBL16619684 | 0.92 | ADRB3 (0.53) | ADRB3SLC6A2KCNH2ADRB2SLC6A4 | |
| SCHEMBL16619503 | 0.89 | ADRB3 (0.42) | ADRB3SLC6A2KCNH2ADRB2SLC6A4 | |
| SCHEMBL16619500 | 0.89 | ADRB3 (0.42) | ADRB3SLC6A2KCNH2ADRB2SLC6A4 | |
| SCHEMBL16619989 | 0.84 | ADRB3 (0.46) | ADRB3SLC6A2KCNH2ADRB2SLC6A4 | |
| SCHEMBL16619987 | 0.84 | ADRB3 (0.46) | ADRB3SLC6A2KCNH2ADRB2SLC6A4 | |
| SCHEMBL16619208 | 0.83 | ADRB3 (0.55) | ADRB3SLC6A2KCNH2ADRB2SLC6A4 | |
| SCHEMBL16619205 | 0.83 | ADRB3 (0.55) | ADRB3SLC6A2KCNH2ADRB2SLC6A4 | |
| SCHEMBL16619356 | 0.83 | ADRB3 (0.42) | ADRB3SLC6A2KCNH2ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3052099-A1 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | Merck Sharp & Dohme Corp. (US) | 2016-08-10 | — | — | EP | disclosed |
| WO-2015050798-A1 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2015-04-09 | — | — | WO | disclosed |